Identifying inhibitors of ATM and ATR kinase activities.
Sarkaria
Jann N
JN
Department of Oncology, Mayo Foundation, Rochester, MN, USA.
D000970:Antineoplastic Agents / Q000494:pharmacology*; D064007:Ataxia Telangiectasia Mutated Proteins; D018797:Cell Cycle Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism; D002712:Chlorides / Q000494:pharmacology; D004249:DNA Damage; D004268:DNA-Binding Proteins; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006801:Humans; D015636:Magnesium Chloride / Q000494:pharmacology; D017895:Manganese Compounds / Q000494:pharmacology; D008863:Microspheres; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism; D011233:Precipitin Tests; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D025521:Tumor Suppressor Proteins
D000970:Antineoplastic Agents; D018797:Cell Cycle Proteins; D002712:Chlorides; D004268:DNA-Binding Proteins; D004791:Enzyme Inhibitors; D017895:Manganese Compounds; D009363:Neoplasm Proteins; D025521:Tumor Suppressor Proteins; D015636:Magnesium Chloride; C576324:ATM protein, human; C576597:ATR protein, human; D064007:Ataxia Telangiectasia Mutated Proteins; D017346:Protein Serine-Threonine Kinases; C025340:manganese chloride